UNSPSC 51101905: Chloroquine

This classification denotes an antimalarial agent with the molecular formula C18H26ClN3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 886U3H6UFF, chemically known as 1,4-pentanediamine, n(sup 4)-(7-chloro-4-quinolinyl)-n(sup 1),n(sup 1)-diethyl- but generally known as chloroquine, which bears US NIH Compound Identifier 2719. European Medicines Agency schedules Chloroquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06196MIG. The term CHLOROQUINE is an International Non-Proprietary Name.

UNSPSC 51101905 Chloroquine (Commodity) covers pharmaceutical procurement by state and local health agencies, but recent solicitations tagged to this code show substantial misdirection — the opportunities solicited reflect naloxone and drug deactivation systems, multi-source generics and OTC products, medical and first aid supplies, and direct-to-manufacturer pharmacy programs rather than chloroquine specifically. State and local governments buying under this Commodity code are primarily health departments, county community health agencies, fire-rescue divisions, and state health and human services commissions acquiring pharmaceuticals and medical supplies for public health, emergency response, and employee benefit programs. The work includes both direct purchase of specific pharmaceutical products (naloxone, generics, OTC medications) and strategic procurement mechanisms such as cooperative purchasing arrangements and direct-to-manufacturer initiatives designed to manage cost and supply chain efficiency.

Recent activity spans Florida, Texas, and Minnesota. Seminole County, Florida (IFB 60459723LAS, due Jul 26, 2023) procured 1,900 units of naloxone and 800 drug deactivation systems annually through competitive bidding for quarterly delivery to county community health operations. The City of Tampa Fire Department (IFB 26P00145, due Mar 13, 2026) sought medical and first aid supplies including respiratory equipment, cardiac monitoring electrodes, and consumables across 169 line items, with an estimated contract value of $700,000 and a small local business enterprise set-aside. The Texas Health and Human Services Commission (RFI HHS0017013, Apr 3, 2026) gathered market intelligence on direct-to-manufacturer prescription programs for state pharmacy benefit management. The Minnesota Multistate Cooperative Purchasing Alliance (RFP S1070000015802, due Mar 26, 2026) established multi-award contracts for generic pharmaceuticals and OTC products across participating state and local facilities in Minnesota and Oregon, with pricing weighted 75 percent on competitiveness and administered through three authorized wholesalers. The code shows no strong recent concentration; activity reflects episodic jurisdictional needs and cooperative purchasing mechanisms rather than sustained demand focused on chloroquine itself.